Center for Scientific Review; Notice of Closed Meetings, 69501-69502 [2014-27561]
Download as PDF
<![CDATA[
69501
Federal Register / Vol. 79, No. 225 / Friday, November 21, 2014 / Notices
• The collections are low-burden for
respondents (based on considerations of
total burden hours, total number of
respondents, or burden-hours per
respondent) and are low-cost for both
the respondents and the Federal
Government;
• The collections are noncontroversial and do not raise issues of
concern to other Federal agencies;
• Any collection is targeted to the
solicitation of opinions from
respondents who have experience with
the program or may have experience
with the program in the near future;
• Personally identifiable information
(PII) is collected only to the extent
necessary and is not retained;
• Information gathered will be used
only internally for general service
improvement and program management
purposes and is not intended for release
outside of the agency;
• Information gathered will not be
used for the purpose of substantially
informing influential policy decisions;
and
• Information gathered will yield
qualitative information; the collections
will not be designed or expected to
yield statistically reliable results or used
as though the results are generalizable to
the population of study.
Feedback collected under this generic
clearance provides useful information,
but it does not yield data that can be
generalized to the overall population.
This type of generic clearance for
qualitative information will not be used
for quantitative information collections
that are designed to yield reliably
actionable results, such as monitoring
of the information to be collected; (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology;
and (e) estimates of capital or start-up
costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid
Office of Management and Budget
control number.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
4,358.
trends over time or documenting
program performance. Such data uses
require more rigorous designs that
address: The target population to which
generalizations will be made, the
sampling frame, the sample design
(including stratification and clustering),
the precision requirements or power
calculations that justify the proposed
sample size, the expected response rate,
methods for assessing potential nonresponse bias, the protocols for data
collection, and any testing procedures
that were or will be undertaken prior to
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other generic
mechanisms that are designed to yield
quantitative results.
As a general matter, information
collections will not result in any new
system of records containing privacy
information and will not ask questions
of a sensitive nature, such as sexual
behavior and attitudes, religious beliefs,
and other matters that are commonly
considered private.
Request for Comments: Comments
submitted in response to this notice will
be summarized and/or included in the
request for OMB approval. Comments
are invited on: (a) Whether the
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
collection of information; (c) ways to
enhance the quality, utility, and clarity
Estimated Annualized Burden Hours
ESTIMATED ANNUAL REPORTING BURDEN
Number of
respondents
Type of collection
Annual
frequency per
response
Hours per
response
Total hours
Customer Satisfaction Surveys .......................................................................
In-Depth Interviews (IDIs) or Small Discussion Groups ..................................
Focus Groups ..................................................................................................
Usability and Pilot Testing ...............................................................................
Conference/Training—Pre and Post Surveys .................................................
1,000
1,000
1,000
150,000
100,000
1
1
1
1
2
30/60
90/60
90/60
5/60
10/60
500
1,500
1,500
12,525
33,333
Total ..........................................................................................................
........................
........................
........................
49,358
mstockstill on DSK4VPTVN1PROD with NOTICES
Dated: November 13, 2014.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2014–27637 Filed 11–20–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
VerDate Sep<11>2014
18:00 Nov 20, 2014
Jkt 235001
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\21NON1.SGM
21NON1
69502
Federal Register / Vol. 79, No. 225 / Friday, November 21, 2014 / Notices
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neuropharmacology.
Date: December 12, 2014.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Richard D. Crosland,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4190,
MSC 7850, Bethesda, MD 20892, 301–435–
1220, crosland@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neuropsychiatric Mechanisms.
Date: December 12, 2014.
Time: 12:30 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Deborah L. Lewis, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4183,
MSC 7850, Bethesda, MD 20892, 301–408–
9129, lewisdeb@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: November 17, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–27561 Filed 11–20–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Citizenship and Immigration
Services
[CIS No. 2551–14; DHS Docket No. USCIS–
2014–0011]
RIN 1615–ZB33
Designation of Liberia for Temporary
Protected Status
U.S. Citizenship and
Immigration Services, Department of
Homeland Security.
ACTION: Notice.
mstockstill on DSK4VPTVN1PROD with NOTICES
AGENCY:
Through this Notice, the
Department of Homeland Security
(DHS) announces that the Secretary of
Homeland Security (Secretary) has
designated Liberia for Temporary
Protected Status (TPS) for a period of 18
SUMMARY:
VerDate Sep<11>2014
18:00 Nov 20, 2014
Jkt 235001
months, effective November 21, 2014
through May 21, 2016. Under section
244(b)(1)(C) of the Immigration and
Nationality Act (INA), 8 U.S.C.
1254a(b)(1)(C), the Secretary is
authorized to designate a foreign state
(or any part thereof) for TPS upon
finding that the foreign state is
experiencing extraordinary and
temporary conditions that prevent its
nationals from returning in safety and
that permitting such aliens to remain
temporarily in the United States is not
contrary to the national interest.
This designation allows eligible
Liberian nationals (and aliens having no
nationality who last habitually resided
in Liberia) who have continuously
resided in the United States since
November 20, 2014 and been
continuously physically present in the
United States since November 21, 2014
to be granted TPS. This Notice also
describes the other eligibility criteria
applicants must meet.
Individuals who believe they may
qualify for TPS under this designation
may apply within the 180-day
registration period that begins on
November 21, 2014 and ends on May
20, 2015. They may also apply for
Employment Authorization Documents
(EADs) and for travel authorization.
Through this Notice, DHS also sets forth
the procedures for nationals of Liberia
(or aliens having no nationality who last
habitually resided in Liberia) to apply
for TPS, EADs, and travel authorization
with U.S. Citizenship and Immigration
Services (USCIS).
Given the Ebola Virus Disease (EVD)related basis for the designations of
Liberia, Guinea, and Sierra Leone for
TPS and ongoing efforts to prevent the
spread of EVD, requests for advance
travel authorization (‘‘advance parole’’)
for travel to one or more of these three
countries will not be approved, as a
matter of discretion, absent
extraordinary circumstances. If you
depart from the United States without
obtaining advance parole or you do not
comply with any conditions that may be
placed on your advance parole
document, you may not be permitted to
re-enter the United States. TPS
beneficiaries who are granted advance
parole to travel to Liberia, Guinea or
Sierra Leone are advised that they, like
other aliens granted advance parole, are
not guaranteed parole into the United
States. A separate decision regarding
your ability to enter will be made when
you arrive at a port-of-entry upon your
return. Individuals considering travel
outside the United States should visit
the Department of State’s Web site for
the most up-to-date information in
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
Travel Alerts and Warnings and in the
Ebola Fact Sheet for Travelers.
DATES: This designation of Liberia for
TPS is effective on November 21, 2014
and will remain in effect through May
21, 2016. The 180-day registration
period for eligible individuals to submit
TPS applications begins November 21,
2014, and will remain in effect through
May 20, 2015.
FOR FURTHER INFORMATION CONTACT:
• For further information on TPS,
including guidance on the application
process and additional information on
eligibility, please visit the USCIS TPS
Web page at https://www.uscis.gov/tps.
You can find specific information
about this designation of Liberia for TPS
by selecting ‘‘TPS Designated Country:
Liberia’’ from the menu on the left of the
TPS Web page.
• You can also contact the TPS
Operations Program Manager at the
Family and Status Branch, Service
Center Operations Directorate, U.S.
Citizenship and Immigration Services,
Department of Homeland Security, 20
Massachusetts Avenue NW.,
Washington, DC 20529–2060; or by
phone at (202) 272–1533 (this is not a
toll-free number). Note: The phone
number provided here is solely for
questions regarding this TPS Notice. It
is not for individual case status
inquires.
• Applicants seeking information
about the status of their individual cases
can check Case Status Online, available
at the USCIS Web site at https://
www.uscis.gov, or call the USCIS
National Customer Service Center at
800–375–5283 (TTY 800–767–1833).
Service is available in English and
Spanish.
• Further information will also be
available at local USCIS offices upon
publication of this Notice.
SUPPLEMENTARY INFORMATION:
Table of Abbreviations
BIA—Board of Immigration Appeals
DHS—Department of Homeland Security
DOS—Department of State
EAD—Employment Authorization Document
EVD—Ebola Virus Disease
FNC—Final Nonconfirmation
IJ—Immigration Judge
INA—Immigration and Nationality Act
OSC—U.S. Department of Justice, Office of
Special Counsel for Immigration-Related
Unfair Employment Practices
SAVE—USCIS Systematic Alien Verification
for Entitlements Program
Secretary—Secretary of Homeland Security
TNC—Tentative Nonconfirmation
TPS—Temporary Protected Status
TTY—Text Telephone
USCIS—U.S. Citizenship and Immigration
Services
WHO—World Health Organization
E:\FR\FM\21NON1.SGM
21NON1
]]>Agencies
[Federal Register Volume 79, Number 225 (Friday, November 21, 2014)]
[Notices]
[Pages 69501-69502]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-27561]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which
[[Page 69502]]
would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Neuropharmacology.
Date: December 12, 2014.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Richard D. Crosland, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4190, MSC 7850, Bethesda, MD
20892, 301-435-1220, crosland@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Neuropsychiatric Mechanisms.
Date: December 12, 2014.
Time: 12:30 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Deborah L. Lewis, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4183, MSC 7850, Bethesda, MD
20892, 301-408-9129, lewisdeb@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS).
Dated: November 17, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-27561 Filed 11-20-14; 8:45 am]
BILLING CODE 4140-01-P
